Literature DB >> 23457379

Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.

Alberto Sulli1, Barbara Ruaro, Vanessa Smith, Carmen Pizzorni, Giuseppe Zampogna, Maurizio Gallo, Maurizio Cutolo.   

Abstract

OBJECTIVE: This study evaluates possible correlations between the pattern of antinuclear antibodies (ANA) on indirect immunofluorescence (IIF) testing and nailfold microangiopathy stage (early, active, and late stage) in systemic sclerosis (SSc). Patients with SSc were followed prospectively to monitor progression of microvascular damage.
METHODS: The ANA pattern on IIF was searched in 42 patients with SSc showing an early pattern of nailfold microangiopathy at baseline, and was followed using nailfold videocapillaroscopy (NVC) for a median time of 91 months.
RESULTS: Among patients whose microangiopathy showed a rapid progression from early to late pattern on NVC, the IIF pattern was fine-speckled + nucleolar (Scl-70+) in 44%, centromeric in 33%, nucleolar in 11%, and homogeneous in 11% of patients with SSc. Antitopoisomerase I antibodies were significantly more frequent (57%) in patients with late pattern of microangiopathy on NVC. The median time of progression from early to active disease was significantly lower in patients with both fine-speckled + nucleolar and nucleolar ANA positivity. The severity of microangiopathy was higher in patients with the nucleolar pattern on IIF. Patients already showing a slight reduction of capillary number at baseline were likely to have either the nucleolar or the fine-speckled + nucleolar pattern on IIF. Of note, 37% of patients still showing the early microangiopathy pattern on NVC at the end of the followup were ANA-negative.
CONCLUSION: ANA-negative patients with SSc display a slower progression of nailfold microangiopathy characterized by the early pattern on NVC. Progression to the late NVC pattern (more advanced stage of microvascular damage) seems to be associated with a different autoantibody pattern on IIF (fine-speckled + nucleolar pattern being the most prevalent).

Entities:  

Keywords:  ANTINUCLEAR ANTIBODIES; INDIRECT IMMUNOFLUORESCENCE; MICROANGIOPATHY; NAILFOLD VIDEOCAPILLAROSCOPY; SCLERODERMA; SYSTEMIC SCLEROSIS

Mesh:

Substances:

Year:  2013        PMID: 23457379     DOI: 10.3899/jrheum.121089

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Body composition and bone status in relation to microvascular damage in systemic sclerosis patients.

Authors:  V Smith; M Cutolo; S Paolino; E Gotelli; F Goegan; A Casabella; G Ferrari; M Patane; M Albertelli; F Gatto; C Pizzorni; F Cattelan; A Sulli
Journal:  J Endocrinol Invest       Date:  2020-05-24       Impact factor: 4.256

2.  Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology.

Authors:  Carmen Pizzorni; Alberto Sulli; Vanessa Smith; Barbara Ruaro; Amelia Chiara Trombetta; Maurizio Cutolo; Sabrina Paolino
Journal:  Clin Rheumatol       Date:  2016-10-08       Impact factor: 2.980

Review 3.  Advances in nailfold capillaroscopic analysis in systemic sclerosis.

Authors:  Barbara Ruaro; Alberto Sulli; Vanessa Smith; Carmen Pizzorni; Sabrina Paolino; Elisa Alessandri; Amelia Chiara Trombetta; Maurizio Cutolo
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09

4.  Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases.

Authors:  Weiru Yuan; Hua Cao; Weiping Li; Xinyi Wu; Jie Zheng
Journal:  Clin Rheumatol       Date:  2021-10-09       Impact factor: 2.980

Review 5.  Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others.

Authors:  Minoru Satoh; Angela Ceribelli; Tomoko Hasegawa; Shin Tanaka
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-08       Impact factor: 10.817

Review 6.  Personalized medicine in rheumatology: the paradigm of serum autoantibodies.

Authors:  Silvia Sirotti; Elena Generali; Angela Ceribelli; Natasa Isailovic; Maria De Santis; Carlo Selmi
Journal:  Auto Immun Highlights       Date:  2017-07-12

Review 7.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19

Review 8.  Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies.

Authors:  Djúlio César Zanin-Silva; Maynara Santana-Gonçalves; Marianna Yumi Kawashima-Vasconcelos; Maria Carolina Oliveira
Journal:  Front Med (Lausanne)       Date:  2021-12-22

9.  Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study.

Authors:  Mara Oleszowsky; Matthias F Seidel
Journal:  Biomed Res Int       Date:  2018-02-01       Impact factor: 3.411

Review 10.  High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?

Authors:  Barbara Ruaro; Elisa Baratella; Paola Confalonieri; Marco Confalonieri; Fabio Giuseppe Vassallo; Barbara Wade; Pietro Geri; Riccardo Pozzan; Gaetano Caforio; Cristina Marrocchio; Maria Assunta Cova; Francesco Salton
Journal:  Diagnostics (Basel)       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.